| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.40▼ | 2.43▼ | 2.43▼ | 2.51▼ | 2.27▼ |
| MA10 | 2.54▼ | 2.65▼ | 2.64▼ | 2.45▼ | 2.04▲ |
| MA20 | 2.71▼ | 2.63▼ | 2.53▼ | 2.41▼ | 1.96▲ |
| MA50 | 2.54▼ | 2.67▼ | 2.69▼ | 2.01▲ | 2.11▲ |
| MA100 | 2.84▼ | 2.61▼ | 2.38▼ | 1.96▲ | N/A |
| MA200 | 2.74▼ | 2.16▲ | 2.10▲ | 2.04▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.070▼ | -0.057▼ | -0.040▼ | -0.031▼ | 0.093▲ |
| RSI | 27.905▼ | 33.080▼ | 36.294▼ | 49.053▼ | 52.313▲ |
| STOCH | 0.000▼ | 6.838▼ | 15.509▼ | 29.593 | 44.300 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -93.077▼ | -58.173 |
| CCI | -142.537▼ | -157.240▼ | -137.275▼ | -98.038 | 110.416▲ |
|
Friday, December 12, 2025 08:00 AM
EMA recommends conditional authorization for ImmunityBio's Anktiva with BCG after a 71% complete response rate in BCG-unresponsive non-muscle invasive bladder cancer.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/12/25 | 2.34 | 2.34 | 2.23 | 2.23 | 40,066 |
| 11/12/25 | 2.86 | 2.985 | 2.52 | 2.53 | 45,830 |
| 10/12/25 | 2.42 | 3.03 | 2.42 | 2.86 | 99,895 |
| 09/12/25 | 2.41 | 2.60 | 2.3301 | 2.49 | 35,825 |
| 08/12/25 | 2.36 | 2.48 | 2.34 | 2.44 | 25,387 |
| 05/12/25 | 2.32 | 2.43 | 2.21 | 2.41 | 61,744 |
| 04/12/25 | 2.44 | 2.5499 | 2.32 | 2.33 | 61,781 |
| 03/12/25 | 2.31 | 2.505 | 2.30 | 2.47 | 79,591 |
| 02/12/25 | 2.46 | 2.46 | 2.321 | 2.35 | 33,426 |
| 01/12/25 | 2.72 | 2.765 | 2.348 | 2.42 | 119,231 |
|
|
||||
|
|
||||
|
|